Urinschnelltests (Immunoassays) auf Drogen und Medikamente ...

21. Cone EJ, Johnson RE. Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke.
Clin Pharmacol Ther. 1986;40(3):247–56.
22. Magerl H, Wiegand C,Schulz E. Cannabinoid intake by passive smoking. Arch Kriminol. 1987;179(1–2):31–7.
23. Westin AA, Slordal L. Passive inhalation of cannabis smoke – is it detectable? Tidsskr Nor Laegeforen.
2009;129(2):109–13.
24. Schimmel I, Drobnik S, Röhrich J, Becker J, Zörntlein S,Urban R. Passive Cannabisexposition unter realistischen
Bedingungen – Untersuchungen in einem Coffee-Shop. Blutalkohol. 2010;47:269–74.
25. Toennes SW, Röhrich J, Wunder C. Interpretation of blood analysis data found after passive exposure to cannabis.
Arch Kriminol. 2010;225(3–4):90–8.
26. George S, Parmar S, Meadway C, Braithwaite RA. Application and validation of a urinary methadone metabolite
(EDDP) immunoassay to monitor methadone compliance. Ann Clin Biochem. 2000;37:350–4.
27. Larson ME, Richards TM. Quantification of a methadone metabolite (EDDP) in urine: assessment of compliance. Clin
Med Res. 2009;7(4): 134–41.
28. Rohrig TP, Moore C. The determination of morphine in urine and oral fluid following ingestion of poppy seeds. J Anal
Toxicol. 2003; 27(7):449–52.
29. Lachenmeier DW, Sproll C,Musshoff F. Poppy seed foods and opiate drug testing – where are we today? Ther Drug
Monit. 2010;32(1):1–18.
30. Jankovicova K, Ulbrich P, Fuknova M. Effect of poppy seed consummation on the positive results of opiates
screening in biological samples. Leg Med (Tokyo). 2009;11(Suppl 1):S416–8.
31. Moeller MR, Hammer K, Engel O. Poppy seed consumption and toxicological analysis of blood and urine samples.
Forensic Sci Int. 2004;143:183–6.
32. Berghaus G, Musshoff F, Madea B. Verkehrsmedizin – Fahreignung, Fahrsicherheit, Unfallrekonstruktion. 1st edition.
Köln: Deutscher Ärzte-Verlag GmbH; 2007.
2